Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis.
Kroes JA, Alfonso-Cristancho R, Bansal AT, Berret E, Bieksiene K, Bourdin A, Brussino L, Canhoto D, Cardini C, Celik G, Csoma Z, Dahlén B, Damadoglu E, Eger K, Gauquelin L, Gemicioglu B, Goksel O, Graff S, Heffler E, Hofstee HB, Howarth P, Jakes RW, Jaun F, Kalinauskaite-Zukauske V, Kopač P, Kwon N, Loureiro CC, Lozoya García V, Masoli M, Rezelj MP, Pérez De Llano L, Popović-Grle S, Ramos-Barbón D, Sà Sousa A, Samitas K, Schleich F, Sirena C, Skrgat S, Zervas E, Zichnalis G, Bel EH, Sont JK, Hashimoto S, Ten Brinke A. Kroes JA, et al. Among authors: ramos barbon d. ERJ Open Res. 2023 Apr 3;9(2):00745-2022. doi: 10.1183/23120541.00745-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 37020841 Free PMC article.
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study.
Frix AN, Heaney LG, Dahlén B, Mihaltan F, Sergejeva S, Popović-Grle S, Sedlak V, Lehtimäki L, Bourdin A, Korn S, Zervas E, Csoma Z, Lúðvíksdóttir D, Butler M, Canonica GW, Grisle I, Bieksiene K, Ten Brinke A, Kuna P, Chaves Loureiro C, Nenasheva NM, Lazic Z, Škrgat S, Ramos-Barbon D, Leuppi J, Gemicioglu B, Bossios A, Porsbjerg CM, Bel EH, Djukanovic R, Louis R. Frix AN, et al. Among authors: ramos barbon d. ERJ Open Res. 2022 Oct 24;8(4):00273-2022. doi: 10.1183/23120541.00273-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36299366 Free PMC article.
Identification of Two Eosinophil Subsets in Induced Sputum from Patients with Allergic Asthma According to CD15 and CD66b Expression.
Curto E, Mateus-Medina ÉF, Crespo-Lessmann A, Osuna-Gómez R, Ujaldón-Miró C, García-Moral A, Galván-Blasco P, Soto-Retes L, Ramos-Barbón D, Plaza V. Curto E, et al. Among authors: ramos barbon d. Int J Environ Res Public Health. 2022 Oct 17;19(20):13400. doi: 10.3390/ijerph192013400. Int J Environ Res Public Health. 2022. PMID: 36293979 Free PMC article.
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial.
Singh D, Brightling CE, Rabe KF, Han MK, Christenson SA, Drummond MB, Papi A, Pavord ID, Molfino NA, Almqvist G, Kotalik A, Hellqvist Å, Gołąbek M, Sindhwani NS, Ponnarambil SS; COURSE study investigators. Singh D, et al. Lancet Respir Med. 2024 Dec 6:S2213-2600(24)00324-2. doi: 10.1016/S2213-2600(24)00324-2. Online ahead of print. Lancet Respir Med. 2024. PMID: 39653044
Factors Associated With Large Airway Collapse in Severe Asthma.
Martinez Rivera C, Serra Mitjà P, Andreo García F, Crespo-Lessmann A, Solis Solis AJ, Torrego A, Garcia-Olive I, Ramos-Barbón D, Zapata Comas T, Plaza V, Abad J, Rosell A. Martinez Rivera C, et al. Among authors: ramos barbon d. Arch Bronconeumol. 2023 Sep;59(9):605-607. doi: 10.1016/j.arbres.2023.05.006. Epub 2023 May 24. Arch Bronconeumol. 2023. PMID: 37296031 Free article. English, Spanish. No abstract available.
Dr. Joseph Milic-Emili (1931-2022).
Ramos Barbón D. Ramos Barbón D. Arch Bronconeumol. 2022 Feb 16:S0300-2896(22)00088-6. doi: 10.1016/j.arbres.2022.02.001. Online ahead of print. Arch Bronconeumol. 2022. PMID: 35312524 English, Spanish. No abstract available.
A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future.
Pérez de Llano L, Miravitlles M, Golpe R, Alvarez-Gutiérrez FJ, Cisneros C, Almonacid C, Martinez-Moragon E, Gonzalez-Barcala FJ, Ramos-Barbón D, Plaza V, Lopez-Campos JL, de-Torres JP, Casanova C, Garcia Rivero JL, Rodriguez Hermosa J, Calle Rubio M, Soler-Cataluña JJ, Cosio BG. Pérez de Llano L, et al. Among authors: ramos barbon d. Int J Chron Obstruct Pulmon Dis. 2020 Sep 4;15:2091-2100. doi: 10.2147/COPD.S263430. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32943862 Free PMC article.
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.
Airway Hyperresponsiveness, Inflammation, and Pulmonary Emphysema in Rodent Models Designed to Mimic Exposure to Fuel Oil-Derived Volatile Organic Compounds Encountered during an Experimental Oil Spill.
Amor-Carro Ó, White KM, Fraga-Iriso R, Mariñas-Pardo LA, Núñez-Naveira L, Lema-Costa B, Villarnovo M, Verea-Hernando H, Ramos-Barbón D. Amor-Carro Ó, et al. Among authors: ramos barbon d. Environ Health Perspect. 2020 Feb;128(2):27003. doi: 10.1289/EHP4178. Epub 2020 Feb 12. Environ Health Perspect. 2020. PMID: 32074461 Free PMC article.
48 results